TY - JOUR T1 - The Canadian Partnership for Tomorrow Project: a pan-Canadian platform for research on chronic disease prevention JF - Canadian Medical Association Journal JO - CMAJ SP - E710 LP - E717 DO - 10.1503/cmaj.170292 VL - 190 IS - 23 AU - Trevor J.B. Dummer AU - Philip Awadalla AU - Catherine Boileau AU - Camille Craig AU - Isabel Fortier AU - Vivek Goel AU - Jason M.T. Hicks AU - Sébastien Jacquemont AU - Bartha Maria Knoppers AU - Nhu Le AU - Treena McDonald AU - John McLaughlin AU - Anne-Marie Mes-Masson AU - Anne-Monique Nuyt AU - Lyle J. Palmer AU - Louise Parker AU - Mark Purdue AU - Paula J. Robson AU - John J. Spinelli AU - David Thompson AU - Jennifer Vena AU - Ma’n Zawati AU - with the CPTP Regional Cohort Consortium Y1 - 2018/06/11 UR - http://www.cmaj.ca/content/190/23/E710.abstract N2 - BACKGROUND: Understanding the complex interaction of risk factors that increase the likelihood of developing common diseases is challenging. The Canadian Partnership for Tomorrow Project (CPTP) is a prospective cohort study created as a population-health research platform for assessing the effect of genetics, behaviour, family health history and environment (among other factors) on chronic diseases.METHODS: Volunteer participants were recruited from the general Canadian population for a confederation of 5 regional cohorts. Participants were enrolled in the study and core information obtained using 2 approaches: attendance at a study assessment centre for all study measures (questionnaire, venous blood sample and physical measurements) or completion of the core questionnaire (online or paper), with later collection of other study measures where possible. Physical measurements included height, weight, percentage body fat and blood pressure. Participants consented to passive follow-up through linkage with administrative health databases and active follow-up through recontact. All participant data across the 5 regional cohorts were harmonized.RESULTS: A total of 307 017 participants aged 30–74 from 8 provinces were recruited. More than half provided a venous blood sample and/or other biological sample, and 33% completed physical measurements. A total of 709 harmonized variables were created; almost 25% are available for all participants and 60% for at least 220 000 participants.INTERPRETATION: Primary recruitment for the CPTP is complete, and data and biosamples are available to Canadian and international researchers through a data-access process. The CPTP will support research into how modifiable risk factors, genetics and the environment interact to affect the development of cancer and other chronic diseases, ultimately contributing evidence to reduce the global burden of chronic disease. ER -